Malaria Journal

official impact factor 3.49

This article is part of the supplement: Coartem®: reviewing the impact on the malaria landscape

Open Access Highly Access Review

The clinical efficacy of artemether/lumefantrine (Coartem®)

Michael Makanga* and Srivicha Krudsood

Malaria Journal 2009, 8(Suppl 1):S5 doi:10.1186/1475-2875-8-S1-S5

No comments have yet been made on this article.

Post a comment